tetano
Editor, Senior Moderator
BMC Pulm Med. 2017 Feb 14;17(1):38. doi: 10.1186/s12890-017-0381-y.
[h=1]Extracorporeal membrane oxygenation for avian influenza A (H7N9) patient with acute respiratory distress syndrome: a case report and short literature review.[/h] Nie Q[SUP]1[/SUP], Zhang DY[SUP]2[/SUP], Wu WJ[SUP]1[/SUP], Huang CL[SUP]1[/SUP], Ni ZY[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Extracorporeal membrane oxygenation (ECMO) is performed as an acceptable life-saving bridging procedure in patients with severe acute respiratory distress syndrome (ARDS).To patients with avian influenza A (H7N9)-associated ARDS, ECMO could be adopted as a feasible therapeutic solution. We present our successful experience with ECMO utilized in a respiratory failure patient with H7N9 infection.
[h=4]CASE PRESENTATION:[/h] A 44 years-old female with H7N9-induced ARDS was admitted to intensive care unit (ICU) and was treated with veno-venous ECMO for six days, antiviral therapy, prolonged corticosteroid infusion and other therapies. She suffered significant hemorrhage requiring transfusion of platelets and multidrug-resistant Acinetobacter Baumannii infection during ECMO support. Bleeding and infection almost killed the patient's life. Fortunately, she was alive at last and completly recovered after 38 days of ICU stay.
[h=4]CONCLUSIONS:[/h] ECMO was effective in this H7N9 patient with a fatal respiratory failure. Mechanical circulatory support was the only chance for our patient with H7N9-associated ARDS to survive until respiratory function recovery. Early detection and rapid response are essential to these serious ECMO-associated complications such as hemorrhage, thrombosis and infection.
[h=4]KEYWORDS:[/h] Acute respiratory distress syndrome; Avian influenza A H7N9; Extracorporeal membrane oxygenation
PMID: 28196469 DOI: 10.1186/s12890-017-0381-y
[PubMed - in process] Free full text
[h=1]Extracorporeal membrane oxygenation for avian influenza A (H7N9) patient with acute respiratory distress syndrome: a case report and short literature review.[/h] Nie Q[SUP]1[/SUP], Zhang DY[SUP]2[/SUP], Wu WJ[SUP]1[/SUP], Huang CL[SUP]1[/SUP], Ni ZY[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Extracorporeal membrane oxygenation (ECMO) is performed as an acceptable life-saving bridging procedure in patients with severe acute respiratory distress syndrome (ARDS).To patients with avian influenza A (H7N9)-associated ARDS, ECMO could be adopted as a feasible therapeutic solution. We present our successful experience with ECMO utilized in a respiratory failure patient with H7N9 infection.
[h=4]CASE PRESENTATION:[/h] A 44 years-old female with H7N9-induced ARDS was admitted to intensive care unit (ICU) and was treated with veno-venous ECMO for six days, antiviral therapy, prolonged corticosteroid infusion and other therapies. She suffered significant hemorrhage requiring transfusion of platelets and multidrug-resistant Acinetobacter Baumannii infection during ECMO support. Bleeding and infection almost killed the patient's life. Fortunately, she was alive at last and completly recovered after 38 days of ICU stay.
[h=4]CONCLUSIONS:[/h] ECMO was effective in this H7N9 patient with a fatal respiratory failure. Mechanical circulatory support was the only chance for our patient with H7N9-associated ARDS to survive until respiratory function recovery. Early detection and rapid response are essential to these serious ECMO-associated complications such as hemorrhage, thrombosis and infection.
[h=4]KEYWORDS:[/h] Acute respiratory distress syndrome; Avian influenza A H7N9; Extracorporeal membrane oxygenation
PMID: 28196469 DOI: 10.1186/s12890-017-0381-y
[PubMed - in process] Free full text